TotalMarketCap

Largest biotechnology: in vitro & in vivo diagnostic substances companies

Every US-listed biotechnology: in vitro & in vivo diagnostic substances company we cover, 19 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.

Combined market cap

$62.622 B

0.06% of all US-listed value

Companies

19

Ranked #99 of 152 industries

Largest

Idexx Laboratories

IDXX ยท market cap

Average

$3.296 B

Mean market cap per company

#NameMarket capCloseSessionCountry
1Idexx LaboratoriesIDXX$40.6B$515.41-2.21% United States
2LantheusLNTH$6.52B$99.95-0.24% United States
3Oruka TherapeuticsORKA$5.31B$80.18-4.98% United States
4NeogenNEOG$2.61B$11.96-8.07% United States
5Celldex TherapeuticsCLDX$2.43B$31.01-4.86% United States
6Intellia TherapeuticsNTLA$1.73B$12.37-2.98% United States
7QuidelOrthoQDEL$862.0M$12.57+3.54% United States
8Achieve Life SciencesACHV$723.4M$7.03+0.28% United States
9Anbio BiotechnologyNNNN$705.1M$4.90+1.45% Germany
10Alpha TeknovaTKNO$469.8M$8.75-2.78% United States
11Myriad GeneticsMYGN$409.4M$4.28-6.55% United States
12Insight Molecular DiagnosticsIMDX$110.6M$3.38-7.90% United States
13ImmucellICCC$90.5M$9.97+2.26% United States
14BiomericaBMRA$9.84M$2.14+4.39% United States
15VolitionrxVNRX$7.30M$0.24+4.70% Singapore
16Cardio DiagnosticsCDIO$5.92M$2.00-2.91% United States
17Trinity BiotechTRIB$5.81M$7.15+23.92% Ireland
18Q/C TechnologiesQCLS$5.65M$0.69+1.41% United States
19Virax Biolabs GroupVRAX$2.73M$2.03-15.42% United Kingdom

All 19 companies. One row per company, with secondary share classes folded into their primary listing. Updated 8 Oct 2026.

Sectors biotechnology: in vitro & in vivo diagnostic substances companies sit in

Other industries

Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.